Exact Mass: 475.1024276
Exact Mass Matches: 475.1024276
Found 78 metabolites which its exact mass value is equals to given mass value 475.1024276,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
E3040 glucuronide
A member of the class of benzothiazoles that is E3040 in which the hydroxy hydrogen at position 6 has been replaced by a beta-D-glucosiduronic acid group. It is a metabolite of the anti-inflammatory drug, E3040.
Ertapenem
Meropenem in which the one of the two methyl groups attached to the amide nitrogen is replaced by hydrogen while the other is replaced by a 3-carboxyphenyl group. The sodium salt is used for the treatment of moderate to severe susceptible infections including intra-abdominal and acute gynaecological infections, pneumonia, and infections of the skin and of the urinary tract. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DH - Carbapenems D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
Cefovecin sodium
C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
Ertapenem
Ertapenem is only found in individuals that have used or taken this drug. It is a carbapenem antibiotic marketed by Merck as Invanz®. It is structurally very similar to meropenem in that it possess a 1-beta-methyl group. [Wikipedia]The bactericidal activity of ertapenem results from the inhibition of cell wall synthesis and is mediated through ertapenem binding to penicillin binding proteins (PBPs). In Escherichia coli, it has strong affinity toward PBPs 1a, 1b, 2, 3, 4 and 5 with preference for PBPs 2 and 3. Ertapenem is stable against hydrolysis by a variety of beta-lactamases, including penicillinases, and cephalosporinases and extended spectrum beta-lactamases. Ertapenem is hydrolyzed by metallo-beta-lactamases. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DH - Carbapenems D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
[(2R,5R)-5-(6-Aminopurin-9-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 2-benzoylbenzoate
C24H21N5O6 (475.14917660000003)
Cys Cys His Asn
Cys Cys Asn His
Cys His Cys Asn
Cys His Asn Cys
Cys Asn Cys His
Cys Asn His Cys
His Cys Cys Asn
His Cys Asn Cys
His Asn Cys Cys
Asn Cys Cys His
Asn Cys His Cys
Asn His Cys Cys
N,N-Bis(4-biphenylyl)-N-(4-bromophenyl)amine
C30H22BrN (475.09355120000004)
TERT-BUTYL 4-(4-(2-BROMOBENZYL)PIPERAZIN-1-YL)-3-NITROBENZOATE
C22H26BrN3O4 (475.1106576000001)
2-[ethyl[4-[(6-nitrobenzothiazol-2-yl)azo]phenyl]amino]ethyl benzoate
C24H21N5O4S (475.1314186000001)
Phenyl N-Benzyl-2-amino-4,6-O-benzylidene-2-N,3-O-carbonyl-2-deoxy-1-thio-beta-D-glucopyranoside
C27H25NO5S (475.14533600000004)
Tegopen
C19H19ClN3NaO6S (475.05807440000007)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
3-[1-Acetyl-5-(2-furanyl)-3-pyrazolidinylidene]-6-bromo-4-phenyl-2-quinolinone
C24H18BrN3O3 (475.05314580000004)
O5-(L-Glutamyl-sulfamoyl)-adenosine
C15H21N7O9S (475.1121416000001)
N2-[(R)-citryl],N5-[(S)-citryl]-D-ornithine
C17H19N2O14-5 (475.08362539999996)
[(2R,5R)-5-(6-Aminopurin-9-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 2-benzoylbenzoate
C24H21N5O6 (475.14917660000003)
Dermatan, 4-(hydrogen sulfate)
C14H21NO15S-2 (475.06318760000005)
B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents D006401 - Hematologic Agents > D000925 - Anticoagulants
3-L-glutaminyl-AMP
An L-glutaminyl derivative that is the ester obtained by formal condensation of the carboxy group of L-glutamine with the 3-hydroxy group of AMP.
2-[(7-methoxy-4-methyl-[1,2,4]triazolo[4,3-a]quinolin-1-yl)thio]-N-methyl-N-(4-phenyl-2-thiazolyl)acetamide
2-O-acetylbulbisine Trifluoroacetic acid
A natural product found in Crinum asiaticum var. sinicum.
1-O-acetylbulbisine Trifluoroacetic acid
A natural product found in Crinum asiaticum var. sinicum.
alpha-L-iduronyl-(1->3)-N-acetyl-D-6-sulfogalactosamine
C14H21NO15S-2 (475.06318760000005)
(3R)-4-(3-bromophenyl)-3-(2-hydroxyethyl)-2-[oxo-(propan-2-ylamino)methyl]-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxylic acid ethyl ester
C22H26BrN3O4 (475.1106576000001)
[(1S)-2-[(4-chlorophenyl)methyl]-7-methoxy-1-methylsulfonyl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanol
C23H26ClN3O4S (475.1332466000001)
(3S)-4-(3-bromophenyl)-3-(2-hydroxyethyl)-2-[oxo-(propan-2-ylamino)methyl]-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxylic acid ethyl ester
C22H26BrN3O4 (475.1106576000001)
[(1R)-2-[(4-chlorophenyl)methyl]-7-methoxy-1-methylsulfonyl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanol
C23H26ClN3O4S (475.1332466000001)
Delta(4)-beta-D-GlcpA-(1->4)-alpha-D-GlcpNAc6S
C14H21NO15S (475.06318760000005)
Delta(4)-beta-D-GlcpA-(1->3)-D-GalpNAc4S
C14H21NO15S (475.06318760000005)
Delta(4)-beta-D-GlcpA-(1->4)-D-GlcpNAc6S
C14H21NO15S (475.06318760000005)
Delta(4)-beta-D-GlcpA2S-(1->3)-alpha-D-GlcpNAc
C14H21NO15S (475.06318760000005)
alpha-L-threo-hex-4-enopyranuronosyl-(1->3)-beta-D-GalpNAc6S
C14H21NO15S (475.06318760000005)
2-(Acetylamino)-4-O-[(4,5-didehydro-2-O-sulfo-1-deoxy-beta-D-glucopyranuronic acid)-1-yl]-2-deoxy-D-glucopyranose
C14H21NO15S (475.06318760000005)
Delta(4)-beta-D-GlcpA-(1->3)-beta-D-GalpNAc4S
C14H21NO15S (475.06318760000005)
(2R,3R,4R)-2-[(3R,4R,5R,6R)-3-Acetamido-2,5-dihydroxy-6-(sulfooxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxy-3,4-dihydro-2H-pyran-6-carboxylic acid
C14H21NO15S (475.06318760000005)
(2S,3R,4R)-2-[(2R,3S,4R,5R,6R)-5-Acetamido-4,6-dihydroxy-2-(sulfooxymethyl)oxan-3-yl]oxy-3,4,5-trihydroxy-3,4-dihydro-2H-pyran-6-carboxylic acid
C14H21NO15S (475.06318760000005)
Sodium cloxacillin monohydrate
C19H17ClN3O5S. Na. H2O (475.05807440000007)
KCC009
C21H22BrN3O5 (475.07427420000005)
KCC009, a transglutaminase 2 (TG2) inhibitor, induces p53-independent radiosensitization[1][2].
(1s,17s,24r,25r)-1,4,19,24,25-pentahydroxy-25-[(1r)-1-hydroxyethyl]-16-azahexacyclo[15.7.1.0²,¹⁵.0⁵,¹⁴.0⁷,¹².0¹⁸,²³]pentacosa-2(15),3,5(14),7,9,11,18,20,22-nonaene-6,13-dione
(1s,17s,24r,25r)-1,4,11,24,25-pentahydroxy-25-[(1r)-1-hydroxyethyl]-16-azahexacyclo[15.7.1.0²,¹⁵.0⁵,¹⁴.0⁷,¹².0¹⁸,²³]pentacosa-2(15),3,5(14),7,9,11,18,20,22-nonaene-6,13-dione
5-{[4,5-bis(2h-1,3-benzodioxol-5-ylmethyl)-1-methylimidazol-2-yl]imino}-2-hydroxy-3-methylimidazol-4-one
C24H21N5O6 (475.14917660000003)
(1r,17s,24s,25r)-25-[(1r)-1,2-dihydroxyethyl]-4,11,24,25-tetrahydroxy-16-azahexacyclo[15.7.1.0²,¹⁵.0⁵,¹⁴.0⁷,¹².0¹⁸,²³]pentacosa-2,4,7,9,11,14,18,20,22-nonaene-6,13-dione
1,4,11,24,25-pentahydroxy-25-(1-hydroxyethyl)-16-azahexacyclo[15.7.1.0²,¹⁵.0⁵,¹⁴.0⁷,¹².0¹⁸,²³]pentacosa-2(15),3,5(14),7,9,11,18,20,22-nonaene-6,13-dione
1'-[(2s,3r,4s,5s,6r)-5-amino-3,4-dihydroxy-6-methyloxan-2-yl]-5,5'-dichloro-3'-hydroxy-[2,2'-biindol]-3-one
C22H19Cl2N3O5 (475.07017040000005)
25-(1,2-dihydroxyethyl)-4,11,24,25-tetrahydroxy-16-azahexacyclo[15.7.1.0²,¹⁵.0⁵,¹⁴.0⁷,¹².0¹⁸,²³]pentacosa-2,4,7,9,11,14,18,20,22-nonaene-6,13-dione
1'-(5-amino-3,4-dihydroxy-6-methyloxan-2-yl)-5,5'-dichloro-3'-hydroxy-[2,2'-biindol]-3-one
C22H19Cl2N3O5 (475.07017040000005)
1-cyclopropyl-8-(difluoromethoxy)-6-fluoro-4-oxo-7-[4-(pyrimidin-2-yl)piperazin-1-yl]quinoline-3-carboxylic acid
C22H20F3N5O4 (475.14673160000007)